![]()  | |
| Names | |
|---|---|
| IUPAC name
 (5R,6S,8S)-Hexyl 6-hydroxy-5-methyl-13-oxo-6,7,8,13,14,15-hexahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacene-6-carboxylate  | |
| Other names
 KT 5720  | |
| Identifiers | |
3D model (JSmol)  | 
|
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.238.838 | 
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C32H31N3O5 | |
| Molar mass | 537.616 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
KT5720 is a kinase inhibitor with specificity towards protein kinase A.[1] It is a semi-synthetic derivative of K252a[2] and analog of staurosporine.
References
- ↑ Makarevich, A. V.; Sirotkin, A. V.; Rafay, J. (2010). "Comparison of Effects of Protein Kinase A, Mitogen-activated Protein Kinase, and Cyclin-dependent Kinase Blockers on Rabbit Ovarian Granulosa Cell Functions". Hormone and Metabolic Research. 42 (13): 936–43. doi:10.1055/s-0030-1267226. PMID 20972940.
 - ↑ CID 3844 from PubChem
 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
